NASDAQ · Biotechnology

Tao Synergies Inc. (TAOX) Stock

$3.84 +0.79% NASDAQ: TAOX Healthcare

Valuation

MetricValue
Price$3.84
Market Cap$28.69M
P/E Ratio-1.11
P/B Ratio1.91
P/S Ratio42.66
EPS (TTM)$-8.81
52-Week High$10.00
52-Week Low$3.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-81.20%
ROA-78.90%
ROCE-41.77%
Gross Margin99.88%
Operating Margin-14.31%
Net Margin-36.15%
Debt/Equity0.00
Current Ratio12.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-13.0M$-16.0M$-8.0M$-7.0M$-9.0M
Net Profit$-13.0M$-6.0M$-6.0M$-13.0M$-29.0M
EPS$-62.75$-20.25$-29.56$-10.99$-8.81
Op Margin————-3025.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$36.0M$39.0M$31.0M$18.0M$26.0M
Total Liabilities$2.0M$3.0M$6.0M$11.0M$4.0M
Cash$34.0M$37.0M$29.0M$18.0M$5.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-11.0M$-5.0M$-5.0M$-6.0M
Investing Cash Flow$0$0$-2.0M$-1.0M$-29.0M
Financing Cash Flow$13.0M$1.0M$0$0$0
Net Cash Flow$28.0M$3.0M$-9.0M$-11.0M$-12.0M
Free Cash Flow$-9.0M$-11.0M$-5.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-3.65
FCF Yield-18.83%
Quick Ratio19.99
Interest Coverage—
Return 1Y-60.50%
Return 3Y-84.14%
Return 5Y-98.46%

Ownership

Insiders Held2.31%
Institutions Held6.29%
Institutions Float Held6.44%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC101,8002026-03-31
Geode Capital Management, LLC88,6442026-03-31
Vanguard Capital Management LLC79,3692026-03-31
Vanguard Fiduciary Trust Co45,4322026-03-31
Summit Financial, LLC43,2752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOLDBoundless Bio, Inc. $2.53 -1.94% -0.92 $56.86M 0.00%
CVKDCadrenal Therapeutics, Inc. $0.91 -2.10% -0.19 $3.25M 0.00%
IBIOiBio, Inc. $0.87 -5.33% -3.46 $56.01M 0.00%
INTSIntensity Therapeutics, Inc. $3.63 -1.36% -0.71 $9.81M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About Tao Synergies Inc.

Tao Synergies Inc. is led by CEO Joshua N. Silverman, employs 4 people, headquartered in US, publicly traded since 2025.

Tao Synergies Inc. (TAOX) stock trades at $3.84 with a market capitalization of $28.69M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.11, reflecting a net loss over the last twelve months, price-to-book of 1.91, price-to-sales of 42.66. Over the past 52 weeks the stock has ranged between $3.06 and $10.00, and currently trades 61.6% below its 52-week high.

On profitability, Tao Synergies Inc. generates a return on equity (ROE) of -81.20% (negative, reflecting a net loss), return on capital employed of -41.77%, an operating margin of -14.31%, a net profit margin of -36.15%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.